Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Busque

Showing results (31-40 of 42) with videos related to

Pageof 5
Sort By:
Blood Cancer Journal|November 5, 2020
Correction: Imatinib mesylate inhibits STAT5 phosphorylation in response to IL-7 and promotes T cell lymphopenia in chronic myelogenous leukemia patientsS Thiant, M M Moutuou, P Laflamme, et al.
Blood Cancer Journal|April 8, 2017
Imatinib mesylate inhibits STAT5 phosphorylation in response to IL-7 and promotes T cell lymphopenia in chronic myelogenous leukemia patientsS Thiant, M M Moutuou, P Laflamme, et al.
Bone Marrow Transplantation|December 12, 2002
Unrelated bone marrow transplantation for leukocyte adhesion deficiencyN J Farinha, M Duval, E Wagner, et al.
American Journal of Hematology|December 1, 1992
Cytogenic characterization of primary refractory anemiaM Gyger, G D'Angelo, R Bélanger, et al.
The New England Journal of Medicine|July 21, 1994
Langerhans'-cell histiocytosis (histiocytosis X)--a clonal proliferative diseaseC L Willman, L Busque, B B Griffith, et al.
ESMO Open|August 8, 2025
Impact of clonal hematopoiesis on cardiovascular outcomes in cancer patients of the UK BiobankM Sun, L Busque, J Sandoval, et al.
Experimental Hematology|May 20, 1998
Quantitative assessment of hematopoietic chimerism after allogeneic bone marrow transplantation has predictive value for the occurrence of irreversible graft failure and graft-vs.-host diseaseM Gyger, C Baron, L Forest, et al.
The American Journal of Medicine|July 1, 1995
Natural killer cell lymphoproliferative disease associated with neuropathyD Leitenberg, R N Eisen, J M Goldstein, et al.
Blood|January 1, 1995
Clonality in juvenile chronic myelogenous leukemiaL Busque, D G Gilliland, J T Prchal, et al.
Bone Marrow Transplantation|December 23, 2015
Favorable long-term outcome of patients with multiple myeloma using a frontline tandem approach with autologous and non-myeloablative allogeneic transplantationI Ahmad, R LeBlanc, S Cohen, et al.
Pageof 5

Showing results (31-40 of 42) with videos related to

Sort By:
Pageof 5
Blood Cancer Journal|November 5, 2020
Correction: Imatinib mesylate inhibits STAT5 phosphorylation in response to IL-7 and promotes T cell lymphopenia in chronic myelogenous leukemia patientsS Thiant, M M Moutuou, P Laflamme, et al.
Blood Cancer Journal|April 8, 2017
Imatinib mesylate inhibits STAT5 phosphorylation in response to IL-7 and promotes T cell lymphopenia in chronic myelogenous leukemia patientsS Thiant, M M Moutuou, P Laflamme, et al.
Bone Marrow Transplantation|December 12, 2002
Unrelated bone marrow transplantation for leukocyte adhesion deficiencyN J Farinha, M Duval, E Wagner, et al.
American Journal of Hematology|December 1, 1992
Cytogenic characterization of primary refractory anemiaM Gyger, G D'Angelo, R Bélanger, et al.
The New England Journal of Medicine|July 21, 1994
Langerhans'-cell histiocytosis (histiocytosis X)--a clonal proliferative diseaseC L Willman, L Busque, B B Griffith, et al.
ESMO Open|August 8, 2025
Impact of clonal hematopoiesis on cardiovascular outcomes in cancer patients of the UK BiobankM Sun, L Busque, J Sandoval, et al.
Experimental Hematology|May 20, 1998
Quantitative assessment of hematopoietic chimerism after allogeneic bone marrow transplantation has predictive value for the occurrence of irreversible graft failure and graft-vs.-host diseaseM Gyger, C Baron, L Forest, et al.
The American Journal of Medicine|July 1, 1995
Natural killer cell lymphoproliferative disease associated with neuropathyD Leitenberg, R N Eisen, J M Goldstein, et al.
Blood|January 1, 1995
Clonality in juvenile chronic myelogenous leukemiaL Busque, D G Gilliland, J T Prchal, et al.
Bone Marrow Transplantation|December 23, 2015
Favorable long-term outcome of patients with multiple myeloma using a frontline tandem approach with autologous and non-myeloablative allogeneic transplantationI Ahmad, R LeBlanc, S Cohen, et al.
Pageof 5